அல்லாத மருத்துவ வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அல்லாத மருத்துவ வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அல்லாத மருத்துவ வளர்ச்சி Today - Breaking & Trending Today

Aeterna Zentaris Reports Second Quarter 2021 Financial Results and Provides Pipeline Program Updates

Aeterna Zentaris Reports Second Quarter 2021 Financial Results and Provides Pipeline Program Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New Jersey , United States , United Kingdom , Lou Gehrig , Michael Teifel , Klaus Paulini , Division Of Neuroimmunology Neuroinfectious Disease At Massachusetts , Company On Twitter , Aeterna Zentaris , Us District Court , Queensland University , Aeterna Zentaris Inc , Vaccine Development Pipeline , European Union , Clinical Development , European Commission , University Of Sheffield , Toronto Stock Exchange , Diagnostics Development Pipeline , Research Agreement , Novo Nordisk , Wall Street , Chief Executive Officer , Michael Levy , Research Director , Neuroinfectious Disease ,

Salarius Pharmaceuticals Announces Aundrietta Duncan, Ph.D., To Present During Virtual Epigenetic Therapeutic Targets Summit

Salarius Pharmaceuticals Announces Aundrietta Duncan, Ph.D., To Present During Virtual Epigenetic Therapeutic Targets Summit
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United States , Aundrietta Duncan , Johanna Bennett , Maureen Mcenroe , Tiberend Strategic Advisors Inc , National Pediatric Cancer Foundation , Salarius Pharmaceuticals , Drug Administration , Salarius Pharmaceuticals Inc , Clinical Development At Salarius Pharmaceuticals , Product Development Award , Research Institute Of Texas , Non Clinical Development , Epigenetic Therapeutic Targets Summit , Rearranged Sarcomas Through Inhibition , Fast Track Designation , Orphan Drug Designation , Rare Pediatric Disease Designation , Cancer Prevention , Research Institute , Strategic Advisors , ஒன்றுபட்டது மாநிலங்களில் , ஜோஹன்னா பென்னட் , மவ்ரீன் அம்கெந்ரொ , தேசிய குழந்தை புற்றுநோய் அடித்தளம் , ப்ராடக்ட் வளர்ச்சி விருது ,

Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer

Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer
as
1
- Draupnir Bio ( Draupnir ), a biotechnology company developing small molecule modulators of PCSK9 to transform the treatment of heart disease, today announces the appointment of Anna Quattropani, PhD, as Chief Discovery Officer (CDO), effective immediately.
Anna brings more than 20 years of experience in drug discovery and development to the role, having established a successful track record in the design of clinical candidates and their development from discovery to the clinic. At Draupnir, Anna will lead internal and external drug discovery and medicinal chemistry efforts in support of Draupnir s growing preclinical pipeline. ....

Merck Serono , David Daley , Andrew Hotchkiss , Margrit Schwarz , Anna Quattropani , Draupnir Bio , Genevieve Wilson , Proprotein Convertase Subtilisin Kexin , Kostenloser Wertpapierhandel , Max Planck Institute , University Of Geneva , Consilium Strategic Communications , Aarhus University , Clinical Development , Chief Discovery , Chief Discovery Officer , Executive Vice President , Non Clinical Development , Executive Committee , Principle Scientist , Organometallic Chemistry , Chief Executive Officer , Chief Operating Officer , Chief Executive , Proprotein Convertase Subtilisin Kexin Type , Gilde Healthcare Partners ,

Aeterna Zentaris Appoints Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer

Aeterna Zentaris Appoints Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Jenene Thomas , Aeterna Zentaris , Michael Teifel , Klaus Paulini , Company On Twitter , European Commission , Technical University Of Darmstadt , Queensland University , University Of Sheffield , Aeterna Zentaris Inc , Toronto Stock Exchange , European Union , Clinical Development , Novo Nordisk , Senior Vice President , Non Clinical Development , Chief Scientific , Chief Executive Officer , Roche Diagnostics , Munich Biotech , Cleara Biotech , Technical University , Litigation Reform Act , License Agreement ,

Lysogene Reports LYS-SAF302 Biomarker Data Presented at the WORLDSymposium™ 2021

Press release content from Business Wire. The AP news staff was not involved in its creation.
Lysogene Reports LYS-SAF302 Biomarker Data Presented at the WORLDSymposium™ 2021
February 15, 2021 GMT
Regulatory News:
Lysogene (Paris:LYS) (FR0013233475 – LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today reports biomarker data from the ongoing AAVance clinical trial with LYS-SAF302 for the treatment of MPS IIIA (NCT03612869) presented at the WORLDSymposium™ 2021 by Dr. Michaël Hocquemiller, Head of Non-Clinical Development, during the Late-Breaking Science session held on Friday, February 12, 2021.
Concentration of heparan sulfate (HS) in the cerebrospinal fluid (CSF) has been analyzed in 9 patients so far, with samples at baseline (n 9), 6 months (n 8) and 12 months (n 5) after LYS-SAF302 administration. The concentration of abnormally elevated HS-derived oligosaccharides in the CSF was reduced from baselin ....

United States , Pralph Laufer , Sarepta Therapeutics Inc , Clinical Development , Non Clinical Development , Late Breaking Science , Chief Scientific Officer , Sarepta Therapeutics , French Autorit , Des March , French Markets Authorities , Durant Des , Business Wire , Products And Services , Western Europe , Product Testing , Diagnosis And Treatment , Genetics Research , Medical Research , Drug Trials , Clinical Trials , Corporate News , Gene Therapy , Diseases And Conditions , ஒன்றுபட்டது மாநிலங்களில் , ரால்ப் லாஃபர் ,